ID

34199

Descrizione

An Observational Study of Case Managed Versus Non-case Managed Initiation of Hemodialysis; ODM derived from: https://clinicaltrials.gov/show/NCT01613404

collegamento

https://clinicaltrials.gov/show/NCT01613404

Keywords

  1. 15/01/19 15/01/19 -
Titolare del copyright

see on clinicaltrials.gov

Caricato su

15 gennaio 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Chronic Kidney Disease NCT01613404

Eligibility Chronic Kidney Disease NCT01613404

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients who initiated hemodialysis and expected to be on hemodialysis for at least 1 year
Descrizione

ID.1

Tipo di dati

boolean

patients initiating hemodialysis requiring treatment (erythropoiesis stimulating agent or red blood cell transfusion) to correct the anemia of chronic kidney disease who are receiving erythropoiesis stimulating agent treatment at study entry or patients who do not require erythropoiesis stimulating agent therapy (hb within or above target range)
Descrizione

ID.2

Tipo di dati

boolean

life expectancy should be more than 12 months
Descrizione

ID.3

Tipo di dati

boolean

Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients contraindicated to receive erythropoiesis stimulating agent therapy (including but not limited to patients who develop pure red cell aplasia following treatment with any erythropoiesis stimulating agent )
Descrizione

ID.4

Tipo di dati

boolean

patients entering the study on any other agent to increase red blood cell mass (such as androgen therapy, or investigational agents, or other non-approved erythropoiesis stimulating agent)
Descrizione

ID.5

Tipo di dati

boolean

patients unwilling or unable to receive erythropoiesis stimulating agent therapy to correct the anemia of chronic kidney disease
Descrizione

ID.6

Tipo di dati

boolean

patients with uncontrolled hypertension
Descrizione

ID.7

Tipo di dati

boolean

patients who for any reason cannot receive adequate antithrombotic treatment
Descrizione

ID.8

Tipo di dati

boolean

Similar models

Eligibility Chronic Kidney Disease NCT01613404

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patients who initiated hemodialysis and expected to be on hemodialysis for at least 1 year
boolean
ID.2
Item
patients initiating hemodialysis requiring treatment (erythropoiesis stimulating agent or red blood cell transfusion) to correct the anemia of chronic kidney disease who are receiving erythropoiesis stimulating agent treatment at study entry or patients who do not require erythropoiesis stimulating agent therapy (hb within or above target range)
boolean
ID.3
Item
life expectancy should be more than 12 months
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
patients contraindicated to receive erythropoiesis stimulating agent therapy (including but not limited to patients who develop pure red cell aplasia following treatment with any erythropoiesis stimulating agent )
boolean
ID.5
Item
patients entering the study on any other agent to increase red blood cell mass (such as androgen therapy, or investigational agents, or other non-approved erythropoiesis stimulating agent)
boolean
ID.6
Item
patients unwilling or unable to receive erythropoiesis stimulating agent therapy to correct the anemia of chronic kidney disease
boolean
ID.7
Item
patients with uncontrolled hypertension
boolean
ID.8
Item
patients who for any reason cannot receive adequate antithrombotic treatment
boolean

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial